Bristol-Myers Squibb Company (BMY) vs Johnson & Johnson (JNJ)
BMY leads on 8 of 15 compared metrics.
A side-by-side comparison of Bristol-Myers Squibb Company and Johnson & Johnson across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
BMY
Bristol-Myers Squibb Company
$57.13Healthcare
JNJ
Johnson & Johnson
$240.87Healthcare
Total return — BMY vs JNJ
growth of $100 · last 30yBMY +171.1%JNJ +885.6%JNJ compounded faster
BMY JNJ
BMY vs JNJ: by the numbers
- •JNJ is the larger company ($579.83B vs $116.66B market cap).
- •BMY trades at the lower earnings multiple (16.05 vs 27.85 P/E).
- •JNJ converts more revenue to profit (21.83% vs 15.01% net margin).
- •JNJ grew revenue faster over the past five years (2.99% vs 2.52% CAGR).
- •BMY pays the higher dividend yield (4.38% vs 2.18%).
Which is better, BMY or JNJ?
Metric tally: BMY 8 · JNJ 7It depends on what you're optimizing for:
ValueBMY(lower P/E)
GrowthJNJ(faster 5Y revenue CAGR)
IncomeBMY(higher dividend yield)
Valuation
| Metric | BMY | JNJ |
|---|---|---|
| P/E ratio | 16.05● | 27.85 |
| Forward P/E | 9.31● | 18.87 |
| P/S ratio | 2.41● | 6.11 |
| P/B ratio | 5.82● | 7.25 |
| PEG ratio | 1.71 | 0.21● |
| EV / EBITDA | 11.03● | 18.71 |
| FCF yield | 10.20%● | 3.02% |
Profitability
| Metric | BMY | JNJ |
|---|---|---|
| Gross margin | 68.75% | 69.12% |
| Operating margin | 25.67% | 26.87%● |
| Net margin | 15.01% | 21.83%● |
| ROE | 36.25%● | 25.92% |
| ROIC | 13.90% | 13.71% |
Dividends
| Metric | BMY | JNJ |
|---|---|---|
| Dividend yield | 4.38%● | 2.18% |
| Payout ratio | 72.25% | 47.51% |
Growth (annualized)
| Metric | BMY | JNJ |
|---|---|---|
| Revenue CAGR (5Y) | 2.52% | 2.99%● |
| EPS CAGR (5Y) | 9.38% | 11.51%● |
| FCF CAGR (5Y) | -2.50% | -2.38%● |
| Total return CAGR (5Y) | 0.74% | 10.93%● |
Frequently asked
- Which is better, BMY or JNJ?
- It depends on your goal. value: BMY (lower P/E); growth: JNJ (faster 5Y revenue CAGR); income: BMY (higher dividend yield). Across all compared metrics, BMY leads 8 to 7.
- Is BMY or JNJ cheaper?
- On trailing earnings, BMY is cheaper: BMY trades at a 16.05 P/E and JNJ at 27.85.
- Which has grown faster, BMY or JNJ?
- Over the past five years, JNJ grew revenue faster — BMY at a 2.52% CAGR versus JNJ at 2.99%.
- Does BMY or JNJ pay a bigger dividend?
- BMY yields 4.38% and JNJ yields 2.18% based on trailing dividends and the latest price.
- Is BMY or JNJ more profitable?
- JNJ runs the higher net margin — BMY at 15.01% versus JNJ at 21.83%.
- Which has been the better investment, BMY or JNJ?
- Over the past 10-year, JNJ delivered the higher annualized total return — BMY at 1.08% versus JNJ at 10.46%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bristol-Myers Squibb P/E ratioJohnson & Johnson P/E ratioBristol-Myers Squibb dividend yieldJohnson & Johnson dividend yieldBristol-Myers Squibb ROEJohnson & Johnson ROEBristol-Myers Squibb operating marginJohnson & Johnson operating marginBristol-Myers Squibb revenue growthJohnson & Johnson revenue growthBristol-Myers Squibb free cash flowJohnson & Johnson free cash flow
Bristol-Myers Squibb & Johnson & Johnson appear in these rankings
Related comparisons
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.